Trials / Completed
CompletedNCT02471638
DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass
PQ Bypass Systems for Femoropopliteal Bypass II (PQB 4 FP II)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Endologix · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
To assess the safety and performance of the PQ Bypass System to access, deliver guidewires and implant stent grafts for a percutaneous fem-pop bypass.
Detailed description
Prospective, single-arm, multi-center, international, non-randomized, pre-market, safety and effectiveness clinical investigation evaluating the PQ Bypass Systems to access, deliver guidewires and implant stent grafts for a percutaneous femoropopliteal (fem-pop) bypass.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PQ Bypass System for Femoropopliteal Bypass | To access, deliver guidewires and implant stent grafts for a percutaneous fem-pop bypass. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2018-09-01
- Completion
- 2020-06-01
- First posted
- 2015-06-15
- Last updated
- 2025-05-23
- Results posted
- 2025-05-23
Locations
8 sites across 6 countries: Chile, Germany, Italy, Latvia, New Zealand, Poland
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02471638. Inclusion in this directory is not an endorsement.